• Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs
    1. Home
    2. Stocks
    3. Jbchepharm Share Price

    J B Chemicals & Pharmaceuticals Share PriceJ B Chemicals & Pharmaceuticals

    Large Cap 8.6k Result
    ₹1,452.8
    -45.6 (-3.04%)
    As on 10 December, 2023 | 12:06 BSE: 506943 NSE: JBCHEPHARMISIN: INE572A01036
    Split

    J B Chemicals & Pharmaceuticals Performance

    Day Range

    • Low 1,441.00
    • High 1,516.05
    ₹ 1,452.8

    52 Week Range

    • Low 875.00
    • High 1,556.50
    ₹ 1,452.8
    • Open Price1,506.05
    • Previous Close1,498.40
    • Volume105318

    Start SIP in J B Chemicals & Pharmaceuticals

    Start SIP

    J B Chemicals & Pharmaceuticals Share Price

    • Over 1 Month -0.64%
    • Over 3 Month 4.41%
    • Over 6 Month 35.94%
    • Over 1 Year 42.55%

    J B Chemicals & Pharmaceuticals Key Statistics

    P/E Ratio 46.3
    PEG Ratio 1.7
    Market Cap Cr 22,525
    Price to Book Ratio 9.1
    EPS 24.9
    Dividend 0.6
    Relative Strength Index 49.09
    Money Flow Index 58.36
    MACD Signal 9.16
    Average True Range 49.13

    J B Chemicals & Pharmaceuticals Investment Rating

    • Master Rating:

    • J B Chemicals & Phar Ltd has an operating revenue of Rs. 3,332.97 Cr. on a trailing 12-month basis. An annual revenue growth of 28% is outstanding, Pre-tax margin of 18% is great, ROE of 16% is good. The company has a reasonable debt to equity of 15%, which signals a healthy balance sheet. It has recently broken out of a base in its weekly chart and is trading around -4% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 91 which is a GREAT score indicating consistency in earnings, a RS Rating of 61 which is FAIR indicating the recent price performance, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 75 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    J B Chemicals & Pharmaceuticals Financials
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 837853699729740716584
    Operating Expenses Qtr Cr 602618538559574548462
    Operating Profit Qtr Cr 235235161169166168122
    Depreciation Qtr Cr 32313128282622
    Interest Qtr Cr 911129862
    Tax Qtr Cr 56543335343617
    Net Profit Qtr Cr 145145891019810183
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 2,8932,228
    Operating Expenses Annual Cr 2,2191,681
    Operating Profit Annual in Cr 665509
    Depreciation Cr 11271
    Interest Annual Cr 345
    Tax Annual Cr 138110
    Net Profit Annual Cr 389361
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 147147
    Cash from Investing Activity Annual Cr 44
    Cash from Financing Annual Activity Cr -138-138
    Net Cash Flow Annual Cr 13
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 2,4422,104
    Fixed Assets Annual Cr 1,8771,222
    Total Non Current Assets Annual Cr 2,0461,386
    Total Current Assets Annual Cr 1,4241,152
    Total Assets Annual Cr 3,4702,538
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 316272
    ROE Annual % 1617
    ROCE Annual % 1922
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2325
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 882896762793809785625
    Operating Expenses Qtr Cr 638664599618625612500
    Operating Profit Qtr Cr 244232164175185173125
    Depreciation Qtr Cr 32313228282622
    Interest Qtr Cr 1012148862
    Tax Qtr Cr 58523535393718
    Net Profit Qtr Cr 1511428810611110585
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 3,1592,463
    Operating Expenses Annual Cr 2,4541,881
    Operating Profit Annual in Cr 696543
    Depreciation Cr 11473
    Interest Annual Cr 365
    Tax Annual Cr 145119
    Net Profit Annual Cr 410385
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 170170
    Cash from Investing Activity Annual Cr 22
    Cash from Financing Annual Activity Cr -138-138
    Net Cash Flow Annual Cr 34
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 2,4802,134
    Fixed Assets Annual Cr 1,8991,238
    Total Non Current Assets Annual Cr 1,9991,333
    Total Current Assets Annual Cr 1,5551,275
    Total Assets Annual Cr 3,5542,607
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 320277
    ROE Annual % 1718
    ROCE Annual % 2023
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2224
    Invest in J B Chemicals & Pharmaceuticals

    J B Chemicals & Pharmaceuticals Technicals

    EMA & SMA

    Current Price
    ₹1,452.8
    -45.6 (-3.04%)
    pointer
    • Bullish Moving Average
    • ___
    • 8
    • Bearish Moving Average
    • ___
    • 8
    • 20 Day
    • ₹1,461.87
    • 50 Day
    • ₹1,438.42
    • 100 Day
    • ₹1,379.36
    • 200 Day
    • ₹1,269.55
    • 20 Day
    • ₹1,475.42
    • 50 Day
    • ₹1,442.75
    • 100 Day
    • ₹1,397.24
    • 200 Day
    • ₹1,224.36

    J B Chemicals & Pharmaceuticals Resistance and Support

    PIVOT
    ₹1,469.95
    Resistance
    First Resistance 1,498.90
    Second Resistance 1,545.00
    Third Resistance 1,573.95
    RSI 49.09
    MFI 58.36
    MACD Single Line 9.16
    MACD 8.51
    Support
    First Resistance 1,423.85
    Second Resistance 1,394.90
    Third Resistance 1,348.80

    J B Chemicals & Pharmaceuticals Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 117,372 6,638,560 56.56
    Week 149,838 9,255,493 61.77
    1 Month 143,772 9,072,019 63.1
    6 Month 135,244 7,024,556 51.94

    J B Chemicals & Pharmaceuticals Result Highlights

    J B Chemicals & Pharmaceuticals Synopsis

    NSE-Medical-Diversified

    J B Chemicals & Phar is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 2884.16 Cr. and Equity Capital is Rs. 15.48 Cr. for the Year ended 31/03/2023. J B Chemicals & Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 18/12/1976 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24390MH1976PLC019380 and registration number is 019380.
    Market Cap 22,598
    Sales 3,117
    Shares in Float 7.13
    No of funds 219
    Yield 1.2
    Book Value 9.24
    U/D Vol ratio
    LTDebt / Equity 16
    Alpha 0.22
    Beta 0.37

    J B Chemicals & Pharmaceuticals

    Owner NameSep-23Jun-23Mar-23Dec-22
    Promoters 53.86%53.91%53.93%53.95%
    Mutual Funds 15.57%15.57%16.17%15.62%
    Insurance Companies 2.45%2.55%2.39%2.4%
    Foreign Portfolio Investors 10.05%9.53%8.62%8.81%
    Financial Institutions/ Banks 0.01%
    Individual Investors 15.33%15.66%15.97%16.71%
    Others 2.74%2.78%2.92%2.5%

    J B Chemicals & Pharmaceuticals Management

    Name Designation
    Mr. Ranjit Shahani Chairman & Ind.Director
    Mr. Nikhil Chopra WholeTime Director & CEO
    Mr. Prashant Kumar Non Executive Director
    Mr. Gaurav Trehan Non Executive Director
    Mr. Sumit Bose Independent Director
    Ms. Padmini Khare Kaicker Independent Director

    J B Chemicals & Pharmaceuticals Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    J B Chemicals & Pharmaceuticals Corporate Action

    Date Purpose Remarks
    2023-11-07 Quarterly Results
    2023-08-09 Quarterly Results
    2023-05-24 Audited Results, Dividend & Stock Split
    2023-02-08 Quarterly Results & Interim Dividend
    2022-11-11 Quarterly Results
    Date Purpose Remarks
    2023-02-18 INTERIM Rs.8.50 per share(425%)Interim Dividend
    2022-02-24 INTERIM Rs.8.50 per share(425%)Interim Dividend
    2021-02-22 INTERIM Rs.8.50 per share(425%)Interim Dividend
    Date Purpose Remarks
    2023-09-18 Split Rs.0.00 split from Rs. 2/- to 1/-.

    J B Chemicals & Pharmaceuticals MF Shareholding

    Name Amount(cr)
    Nippon India Small Cap Fund - Growth 41,019
    Nippon India Multi Cap Fund - Growth 22,695
    Axis Midcap Fund Growth 21,962
    Nippon India Growth Fund - Growth 21,380
    Axis Small Cap Fund Regular Growth 16,369

    J B Chemicals & Pharmaceuticals FAQs

    What is Share Price of J B Chemicals & Pharmaceuticals ?

    J B Chemicals & Pharmaceuticals share price is ₹1,452 As on 10 December, 2023 | 11:52

    What is the Market Cap of J B Chemicals & Pharmaceuticals ?

    The Market Cap of J B Chemicals & Pharmaceuticals is ₹22524.8 Cr As on 10 December, 2023 | 11:52

    What is the P/E ratio of J B Chemicals & Pharmaceuticals ?

    The P/E ratio of J B Chemicals & Pharmaceuticals is 46.3 As on 10 December, 2023 | 11:52

    What is the PB ratio of J B Chemicals & Pharmaceuticals ?

    The PB ratio of J B Chemicals & Pharmaceuticals is 9.1 As on 10 December, 2023 | 11:52

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.